[go: up one dir, main page]

EP1430112A4 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides

Info

Publication number
EP1430112A4
EP1430112A4 EP02780359A EP02780359A EP1430112A4 EP 1430112 A4 EP1430112 A4 EP 1430112A4 EP 02780359 A EP02780359 A EP 02780359A EP 02780359 A EP02780359 A EP 02780359A EP 1430112 A4 EP1430112 A4 EP 1430112A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02780359A
Other languages
German (de)
English (en)
Other versions
EP1430112A2 (fr
Inventor
Tom Y Tang
Jie Zhang
Feiyan Ren
Aidong J Xue
Qing A Zhao
Jian-Rui Wang
Tom Wehrman
Ping Zhou
Malabika Ghosh
Dunrui Wang
Yunqing Ma
Vinod Asundi
Zhiwei Wang
Gezhi Weng
Dana Haley-Vicente
Rodoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1430112A2 publication Critical patent/EP1430112A2/fr
Publication of EP1430112A4 publication Critical patent/EP1430112A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP02780359A 2001-09-24 2002-09-24 Nouveaux acides nucleiques et polypeptides Withdrawn EP1430112A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32463101P 2001-09-24 2001-09-24
US324631P 2001-09-24
PCT/US2002/030474 WO2003029271A2 (fr) 2001-09-24 2002-09-24 Nouveaux acides nucleiques et polypeptides

Publications (2)

Publication Number Publication Date
EP1430112A2 EP1430112A2 (fr) 2004-06-23
EP1430112A4 true EP1430112A4 (fr) 2005-06-15

Family

ID=23264420

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02780359A Withdrawn EP1430112A4 (fr) 2001-09-24 2002-09-24 Nouveaux acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1430112A4 (fr)
AU (1) AU2002343417A1 (fr)
CA (1) CA2461280A1 (fr)
WO (1) WO2003029271A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
DK1854809T3 (da) 2000-08-22 2013-01-21 Agensys Inc Nukleinsyre og tilsvarende protein betegnet 158P1D7, der er anvendelig i behandling og påvisning af blærecancer og andre cancere
AU2002230831A1 (en) 2000-10-20 2002-04-29 Millennium Pharmaceuticals, Inc. Compositions of human proteins and method of use thereof
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
MXPA03009510A (es) * 2001-04-17 2005-04-29 Univ Arkansas Secuencias de repeticion del gen ca125 y su uso para intervenciones de diagnosticos y terapeuticas.
FR2836687A1 (fr) 2002-03-04 2003-09-05 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
KR20060013425A (ko) * 2003-05-29 2006-02-09 밀레니엄 파머슈티컬스 인코퍼레이티드 유방암의 확인, 평가, 예방 및 요법에 대한 조성물, 키트및 방법
GB0326197D0 (en) * 2003-11-10 2003-12-17 Randox Lab Ltd Molecular marker
JPWO2005111213A1 (ja) * 2004-05-18 2008-03-27 学校法人 久留米大学 Ｍｙｃ標的遺伝子ｍｉｍｉｔｉｎ
WO2006035741A1 (fr) 2004-09-29 2006-04-06 Dainippon Sumitomo Pharma Co., Ltd. Gène exprimé spécifiquement dans les cellules es et utilisation dudit gène
GB0526212D0 (en) * 2005-12-22 2006-02-01 Imp College Innovations Ltd Methods
GB2450840B (en) 2006-05-11 2010-12-29 Quark Pharmaceuticals Inc Screening Systems Utilizing RTP801
EP2026843A4 (fr) 2006-06-09 2011-06-22 Quark Pharmaceuticals Inc Utilisations thérapeutiques d'inhibiteurs de rtp801l
EP1955705B1 (fr) * 2007-02-09 2013-04-17 Gene Signal International Sa Agent et composition de cicatrisation
EP1980254A1 (fr) * 2007-04-13 2008-10-15 Rijksuniversiteit te Groningen Moyens et procédé de annihilation d'agrégation de protéine
EP2178551A4 (fr) * 2007-07-24 2010-07-21 Sanare Invest As Nouveaux peptides
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
JP2013099253A (ja) * 2010-03-11 2013-05-23 Intec Systems Institute Inc 肺癌または子宮頸癌の診断マーカー
US8288334B2 (en) * 2010-06-14 2012-10-16 Gene Signal International Sa Peptides for wound healing
US20130210739A1 (en) * 2010-07-21 2013-08-15 Universite Pierre Et Marie Curie (Paris 6) Bhlh proteins and their use as drugs
MX2013003153A (es) 2010-09-22 2013-05-01 Alios Biopharma Inc Analogos de nucleotidos sustituidos.
AU2012358804B2 (en) 2011-12-22 2018-04-19 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
EP2828277A1 (fr) 2012-03-21 2015-01-28 Vertex Pharmaceuticals Incorporated Formes solides d'un promédicament nucléotidique thiophosphoramidate
WO2013142157A1 (fr) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Combinaisons pharmaceutiques comprenant un analogue thionucléotidique
AU2013305534B2 (en) 2012-08-23 2018-05-31 Agensys, Inc. Antibody drug conjugates (ADC) that bind to 158P1D7 proteins
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
HRP20230878T8 (hr) 2015-03-27 2024-02-16 Immatics Biotechnologies Gmbh Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raznih karcinoma (seq id 25 - mrax5-003)
JP2024516542A (ja) * 2021-04-06 2024-04-16 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Ｍｈｃクラスｉペプチドを含む方法および組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
WO2001079449A2 (fr) * 2000-04-18 2001-10-25 Hyseq, Inc. Acides nucleiques et polypeptides nouveaux
WO2002081629A2 (fr) * 2001-04-03 2002-10-17 Curagen Corporation Nouvelles proteines humaines, polynucleotides codant celles-ci et procede d'utilisation de ceux-ci

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
WO2001079449A2 (fr) * 2000-04-18 2001-10-25 Hyseq, Inc. Acides nucleiques et polypeptides nouveaux
WO2002081629A2 (fr) * 2001-04-03 2002-10-17 Curagen Corporation Nouvelles proteines humaines, polynucleotides codant celles-ci et procede d'utilisation de ceux-ci

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 18 December 2001 (2001-12-18), "Novel human secreted protein #547.", XP002314713, retrieved from EBI accession no. GSP:AAU30056 Database accession no. AAU30056 *
DATABASE Geneseq [online] 5 February 2003 (2003-02-05), "Human protein NOV20a.", XP002314714, retrieved from EBI accession no. GSP:ABU11055 Database accession no. ABU11055 *
DATABASE UniProt [online] 1 June 2001 (2001-06-01), "Hemoglobin alpha 1 globin chain (Fragment).", XP002314712, retrieved from EBI accession no. UNIPROT:Q9BX83 Database accession no. Q9BX83 *
DATABASE USPTO Proteins [online] 10 December 1998 (1998-12-10), "Sequence 3 from patent US 5750345.", retrieved from EBI accession no. USPOP:AR007678 Database accession no. AR007678 *

Also Published As

Publication number Publication date
WO2003029271A2 (fr) 2003-04-10
EP1430112A2 (fr) 2004-06-23
AU2002343417A1 (en) 2003-04-14
CA2461280A1 (fr) 2003-04-10
WO2003029271A3 (fr) 2003-11-20

Similar Documents

Publication Publication Date Title
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1470238A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1430112A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1453967A4 (fr) Bgl5 beta-glucosidase et acides nucleiques codant ce dernier
ATE554171T1 (de) Rezeptor-nukleinsäuren und -polypeptide
EP1453968A4 (fr) Beta-glucosidase bgl4 et acides nucleiques la codant
EP1427746A4 (fr) Systemes d'expression de proteines et d'acides nucleiques
EP1472359A4 (fr) Endoglucanase egvii et acides nucleiques la codant
EP1504099A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1432800A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1556490A4 (fr) Nouveaux acides nucleiques et polypeptides
DK1689775T3 (da) GAG-bindende proteiner
DE02784674T1 (de) Quantifizierung von polypeptiden
DE60210864D1 (de) Modifiziertes fluoreszentes Protein
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1494697A4 (fr) Variants proteiques fluorescents monomeres et dimeres et leurs procedes de fabrication
EP1483386A4 (fr) Nouveaux acides nucleiques et polypeptides secretes
DK1330525T3 (da) NOD2-nukleinsyrer og proteiner
EP1383533A4 (fr) Proteines et acides nucleiques codant pour celles-ci
EP1274716A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1499723A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1498486A4 (fr) Bibliotheque d'acides nucleiques et bibliotheque de proteines
AU2002367841A8 (en) Bsnd nucleic acids and proteins
EP1398376A4 (fr) Acides nucleiques isoles dans le neuroblastome
EP1457557A4 (fr) Nouvelles proteines et adn correspondants

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040322

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050503

17Q First examination report despatched

Effective date: 20050620

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050818